Toremifene (Fareston) — Research Compounds Library | RetatrutideCompare
Selective estrogen-receptor modulator structurally related to tamoxifen. FDA-approved for metastatic breast cancer in postmenopausal women with ER-positive or unknown tumors.
Selective estrogen-receptor modulator structurally related to tamoxifen. FDA-approved for metastatic breast cancer in postmenopausal women with ER-positive or unknown tumors.